FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,876,000 | -58.2% | 550,000 | 0.0% | 0.15% | -63.7% |
| Q2 2021 | $4,483,000 | -33.7% | 550,000 | 0.0% | 0.41% | -23.9% |
| Q1 2021 | $6,765,000 | -32.6% | 550,000 | 0.0% | 0.54% | -29.8% |
| Q4 2020 | $10,043,000 | +17.0% | 550,000 | 0.0% | 0.77% | +0.3% |
| Q3 2020 | $8,586,000 | – | 550,000 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,466,507 | $6,217,990 | 9.26% |